Nonprofit awards 10 Houston companies over $30,000 in grant funding

founders first

Ten Houston companies received funding from the Founders First CDC's Job Creators Quest Grant. Photo courtesy

A national nonprofit has granted $100,000 in funding to 31 companies across the state. Ten of the recipients are based in Houston.

Founders First CDC — an organization that supports diverse founder-led, revenue-generating businesses — named the winners of its new Job Creators Quest Grant this week. Over 600 Texas businesses applied, and the selected recipients represent industries from construction and manufacturing to STEM and healthcare, to hospitality, and more.

"The challenges of simply keeping the doors open have been amplified by an unforeseen obstacle – the pandemic. Now more than ever it takes commitment, perseverance and healthy funding to succeed, which is why I'm excited about Founders First CDC," says Texas State Senator and small business owner, Royce West, in a news release. "This organization is providing small businesses with wherewithal to create jobs, which in turn help sustain operations, achieve business goals and stimulate the economy."

Launched earlier this year, the Job Creators Quest Grant is funding businesses to help them retain and grow their workforce through the pandemic. Since its inception, the program has awarded more than $220,000 to minority and underrepresented business owners throughout the United States.

"We have observed many founders working more in their business than on their business. Our priority is to give entrepreneurs resources to grow while simultaneously becoming premium wage job creators within their community," says Shaylon Scott, executive director of Founders First CDC, in the release. "Investing in diverse entrepreneurs is an impactful way to drive job and wealth creation in underserved communities. The Job Creators Quest Grant is more than a dollar amount, it's a celebration of their success."

Eligibility requirements included the company's founder must be Black, indigenous, a person of color, LGBTQIA+, military veteran, woman or located in a low to moderate income area and be a for-profit company with annual revenues between $100,000 to $3 million. Grant winners will use the funds to help create and add 1-2 net new premium wage jobs in the next 12 months. The program was funded by a $1 million grant from the Rockefeller Foundation, along with Founders First CDC Capital Partners' recent $9 million series A.

The Houston companies that received funding were:

  • DM Electrical and Construction LLC - $10,000
  • Medley Inc. - $10,000
  • EFS GROUP PLLC - $2,500
  • AtWork Personnel Services - $2,500
  • Camellia Alise, LLC - $1,500
  • Flava Wings - $1,500
  • Oops Steam Cleaning - $1,500
  • The Body: A Home for Love - $1,500
  • TNR Accounting & Management Consulting, LLC - $2,500
  • Socium Solutions LLC - $2,500

The other Texas companies that received grant money were:

  • COCINA 54 (Austin) - $1,500
  • Laundris Corp (Austin) - $1,500
  • Center for Music Therapy, Inc. (Austin) - $1,500
  • Le Rouge Cuisine Food Company (Dallas) - $5,000
  • TDG Scientific (Dallas) - $5,000
  • SCENT & FIRE CANDLE COMPANY (Dallas) - $2,500
  • brittani (Dallas) - $2,500
  • Atmospheric Home Staging (Dallas) - $1,500
  • RD Adams Enterprise LLC dba ONE Elite Staffing (Dallas) - $1,500
  • Civil Pour (Dallas) - $1,500
  • Lalloon Marketing Group, LLC dba Imperium Surgical Partners (Dallas) - $1,500
  • WEST ONE PRODUCTS LLC (Fort Worth) - $1,500
  • Hooked On Code, LLC (Frisco) - $5,000
  • Hustle Clean (Frisco) - $5,000
  • PriceSenz LLC (Irving) - $1,500
  • R2R Palliative and Hospice Care LLC (Lewisville) - $1,500
  • Bernadette Davis Communications (Plano) - $1,500
  • Channel Source Inc (Southlake) - $5,000
  • KoderLabs (Trophy Club) - $1,500
  • Brisco Wheel Repair LLC DBA Alloy Wheel Repair of San Antonio (San Antonio) - $1,500
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston clean hydrogen startup to pilot tech with O&G co.

stay gold

Gold H2, a Houston-based producer of clean hydrogen, is teaming up with a major U.S.-based oil and gas company as the first step in launching a 12-month series of pilot projects.

The tentative agreement with the unnamed oil and gas company kicks off the availability of the startup’s Black 2 Gold microbial technology. The technology underpins the startup’s biotech process for converting crude oil into proprietary Gold Hydrogen.

The cleantech startup plans to sign up several oil and gas companies for the pilot program. Gold H2 says it’s been in discussions with companies in North America, Latin America, India, Eastern Europe and the Middle East.

The pilot program is aimed at demonstrating how Gold H2’s technology can transform old oil wells into hydrogen-generating assets. Gold H2, a spinout of Houston-based biotech company Cemvita, says the technology is capable of producing hydrogen that’s cheaper and cleaner than ever before.

“This business model will reshape the traditional oil and gas industry landscape by further accelerating the clean energy transition and creating new economic opportunities in areas that were previously dismissed as unviable,” Gold H2 says in a news release.

The start of the Black 2 Gold demonstrations follows the recent hiring of oil and gas industry veteran Prabhdeep Singh Sekhon as CEO.

“With the proliferation of AI, growth of data centers, and a national boom in industrial manufacturing underway, affordable … carbon-free energy is more paramount than ever,” says Rayyan Islam, co-founder and general partner at venture capital firm 8090 Industries, an investor in Gold H2. “We’re investing in Gold H2, as we know they’ll play a pivotal role in unleashing a new dawn for energy abundance in partnership with the oil industry.”

------

This article originally ran on EnergyCapital.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes an e-commerce startup founder, an industrial biologist, and a cellular scientist.

Omair Tariq, co-founder and CEO of Cart.com

Omair Tariq of Cart.com joins the Houston Innovators Podcast to share his confidence in Houston as the right place to scale his unicorn. Photo via Cart.com

Houston-based Cart.com, which operates a multichannel commerce platform, has secured $105 million in debt refinancing from investment manager BlackRock.

The debt refinancing follows a recent $25 million series C extension round, bringing Cart.com’s series C total to $85 million. The scaleup’s valuation now stands at $1.2 billion, making it one of the few $1 billion-plus “unicorns” in the Houston area.

Cart.com was co-founded by CEO Omair Tariq in October 2020. Read more.

Nádia Skorupa Parachin, vice president of industrial biotechnology at Cemvita

Nádia Skorupa Parachin joined Cemvita as vice president of industrial biotechnology. Photo courtesy of Cemvita

Houston-based biotech company Cemvita recently tapped two executives to help commercialize its sustainable fuel made from carbon waste.

Nádia Skorupa Parachin came aboard as vice president of industrial biotechnology, and Phil Garcia was promoted to vice president of commercialization.

Parachin most recently oversaw several projects at Boston-based biotech company Ginkjo Bioworks. She previously co-founded Brazilian biotech startup Integra Bioprocessos. Read more.

Han Xiao, associate professor of chemistry at Rice University

The funds were awarded to Han Xiao, a chemist at Rice University.

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories. Xiao will use the five-year grant to advance his work on noncanonical amino acids.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement. Read more.

Houston chemist lands $2M NIH grant for cancer treatment research

future of cellular health

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories.

Xiao will use the five-year grant to develop noncanonical amino acids (ncAAs) with diverse properties to help build proteins, according to a statement from Rice. He and his team will then use the ncAAs to explore the vivo sensors for enzymes involved in posttranslational modifications (PTMs), which play a role in the development of cancers and neurological disorders. Additionally, the team will look to develop a way to detect these enzymes in living organisms in real-time rather than in a lab.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement.

According to Rice, these developments could have major implications for the way diseases are treated, specifically for epigenetic inhibitors that are used to treat cancer.

Xiao helped lead the charge to launch Rice's new Synthesis X Center this spring. The center, which was born out of informal meetings between Xio's lab and others from the Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center at the Baylor College of Medicine, aims to improve cancer outcomes by turning fundamental research into clinical applications.

They will build upon annual retreats, in which investigators can share unpublished findings, and also plan to host a national conference, the first slated for this fall titled "Synthetic Innovations Towards a Cure for Cancer.”

View All Listings